Chubing Tan

Title: Chubing Tan: Innovator in Pharmaceutical Research

Introduction

Chubing Tan is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative compounds for treating various medical conditions. With a total of three patents to his name, Tan's work is recognized for its potential impact on healthcare.

Latest Patents

Chubing Tan's latest patents include groundbreaking inventions that focus on the treatment of diabetes and cardiovascular diseases. One of his notable patents is for a sodium glucose cotransporter 2 (SGLT2) inhibitor with a phenyl C-glucoside structure. This invention outlines a preparation method and a pharmaceutical composition that can be used in treating diabetes, providing a new avenue for anti-diabetes medicaments. The compound is characterized by a general formula that includes various substituents, allowing for a range of applications.

Another significant patent involves a thienopyridine ester derivative containing a cyano group. This invention details a compound that exhibits antiplatelet aggregation activity, which can be utilized in the prevention and treatment of cardiac and cerebral vascular diseases. The potential applications of this compound include addressing conditions such as coronary artery syndromes and myocardial infarction.

Career Highlights

Chubing Tan is affiliated with the Tianjin Institute of Pharmaceutical Research, where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on creating effective pharmaceutical solutions.

Collaborations

Tan collaborates with esteemed colleagues in his field, including Lida Tang and Guilong Zhao. These partnerships enhance the research environment and contribute to the successful development of new pharmaceutical compounds.

Conclusion

Chubing Tan is a prominent inventor whose work in pharmaceutical research has the potential to significantly impact the treatment of diabetes and cardiovascular diseases. His innovative patents reflect a dedication to improving healthcare outcomes through scientific advancement.